Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Orthostatic hypotension: epidemiology, pathophysiology and management

G Jacob1, D Robertson

  • 1Clinical Research Center, Vanderbilt University, Nashville, Tennessee, USA.

Current Opinion in Nephrology and Hypertension
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orthostatic intolerance in Behcet's disease.

Autonomic neuroscience : basic & clinical·2001
Same author

Familial orthostatic tachycardia due to norepinephrine transporter deficiency.

Annals of the New York Academy of Sciences·2001
Same author

The Ca(2+) status of the endoplasmic reticulum is altered by induction of calreticulin expression in transgenic plants.

Plant physiology·2001
Same author

Can simultaneous inhibition of seedling growth and stimulation of rhizosphere bacterial populations provide evidence for phytotoxin transfer from plant residues in the bulk soil to the rhizosphere of sensitive species?

Journal of chemical ecology·2001
Same author

Gene pill patents a surprise for gene therapy.

Nature biotechnology·2001
Same author

Origin of the noradrenergic innervation of the superior olivary complex in the rat.

Journal of chemical neuroanatomy·2001
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

Orthostatic hypotension causes low blood pressure and brain hypoperfusion. Tailored therapies can help manage this condition, though it remains challenging, especially in Shy-Drager syndrome.

Area of Science:

  • Cardiology
  • Neurology
  • Gerontology

Background:

  • Orthostatic hypotension (OH) is defined by reduced blood pressure upon standing, leading to symptoms of reduced brain blood flow.
  • OH presents heterogeneously, necessitating accurate diagnosis for effective management and prognosis.
  • While not typically curable, OH can be significantly improved with personalized treatment strategies.

Purpose of the Study:

  • To emphasize the importance of accurate pathophysiologic diagnosis in orthostatic hypotension.
  • To highlight the benefits of individually tailored therapeutic approaches for OH.
  • To acknowledge the challenges in managing OH, particularly in the context of Shy-Drager syndrome.

Main Methods:

  • This study is a review of the pathophysiology and management of orthostatic hypotension.
Keywords:
NASA Discipline Regulatory PhysiologyNon-NASA Center

Related Experiment Videos

  • Diagnostic criteria for orthostatic hypotension were evaluated.
  • Therapeutic strategies were assessed based on individual patient needs and underlying causes.

    • Main Results:

    • Accurate diagnosis of the underlying cause of orthostatic hypotension is crucial.
    • Personalized treatment plans can lead to substantial symptomatic improvement in patients with OH.
    • Management of orthostatic hypotension associated with Shy-Drager syndrome (multiple-system atrophy) presents significant difficulties.

    Conclusions:

    • Effective management of orthostatic hypotension hinges on precise pathophysiologic diagnosis.
    • Tailored therapies offer significant benefits for patients with orthostatic hypotension.
    • Shy-Drager syndrome poses a particularly complex challenge in the management of orthostatic hypotension.